Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
BDSX
#3388
Biodesix, Inc. Common Stock
14.760
0
USD
+1.79%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
+1.79%
Monatliche Änderung
+1.64%
6 month change
+17.99%
Jahresänderung
+17.99%
Vorheriger Schlusskurs
14.500
0
Open
14.760
0
Bid
Ask
Low
14.760
0
High
14.760
0
Volumen
8
Märkte
Aktien
Gesundheitswesen
BDSX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
7.3 M
7.33 M
7.33 M
7.96 M
9.86 M
—
Valuation ratios
Enterprise value
-15.03 M
-13.02 M
-18.66 M
43.46 M
48.05 M
59.83 M
Price to earnings ratio
-0.23
-0.12
-0.05
-1.46
-1.46
-3.09
Price to sales ratio
0.14
0.05
0.03
0.67
0.58
1.33
Price to cash flow ratio
-0.2
-0.09
-0.06
-1.93
-2.21
-4.29
Price to book ratio
0.48
0.04
0.03
1.62
-20.83
-19.14
Enterprise value to EBITDA ratio
0.45
0.48
0.66
-1.62
-1.84
-2.32
Profitability ratios
Return on assets %
0.08
0.13
0.13
0.1
0.05
0.4
Return on equity %
0.4
1
10.08
5.06
1.61
17.76
Return on invested capital %
44.17
61.2
66.23
47.83
13.29
188.54
Gross margin %
97.87
99.44
99.96
100
99.75
399.15
Operating margin %
32.55
50.87
48.55
32.39
6.84
138.66
EBITDA margin %
-24.85
-43.64
-41.6
-25.96
-0.03
-111.23
Net margin %
40.39
61.82
57.29
40.04
13.84
172.99
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.76
2.22
2.14
1.84
1.86
8.07
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.2
0.2
0.23
0.25
0.33
1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.37
0.43
0.53
0.53
0.54
2.03
Long term debt to total equity ratio
1.74
3.32
41.11
27.36
19.25
91.03
Per share metrics
Operating cash flow per share
0.63
1.17
0.9
1.18
-0.1
3.15
EBIT per share
-1.09
-1.26
-1.33
-0.94
-0.27
-3.8
EBITDA per share
-0.78
-1.07
-1.14
-0.75
-0
-2.96
Total debt per share
—
—
—
—
—
—
Cash per share
4.04
2.4
2.83
2.21
2.51
9.96
Net current asset value per share
6.09
4.04
4.42
4.45
4.31
17.23
Tangible book value per share
-0
-1.27
-2.56
-2.36
-2.18
-8.37
Working capital per share
3.88
2.23
2.36
2.03
2
8.61
Book value per share
3.22
1.51
0.16
0.23
0.33
2.22
Nachrichten
Biodesix veröffentlicht Validierungsstudie für Lungenrundherd-Biomarker
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
Here's Why Investors Continue to Hold Pediatrix Medical Stock
Biodesix at TD Cowen Conference: Lung Diagnostics Expansion
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet
Are Medical Stocks Lagging Biodesix (BDSX) This Year?
Starke Q4-Zahlen: Canaccord bekräftigt "Buy"-Rating für Biodesix
Canaccord reiterates Biodesix stock rating on strong Q4 results
3 Best Stocks to Buy Today with 125%+ Upside, 2/27/2026, According to Top Analysts - TipRanks.com
William Blair stuft Biodesix hoch: Starke Geschäftsentwicklung überzeugt
William Blair upgrades Biodesix stock rating on execution momentum
Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript